On the other hand, immunosuppressive checkpoint ligands and cytokines, as synthesized by tumor cells, attenuate the immune response by binding of the checkpoint ligand PD-L1, which has been described in human PAs [116,118,119,120,121]. Here, CD274 is linked to neoplasm.